Childrens Oncology Group

Philadelphia, Pennsylvania 19104

0 studies enrolling now · 41 studies all time

What they study most

Acute Lymphoblastic Leukemia, Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11, Adult Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1, Adult Acute Myeloid Leukemia in Remission, Adult Acute Promyelocytic Leukemia With PML-RARA, Adult B Acute Lymphoblastic Leukemia, Adult Immunoblastic Lymphoma, Adult Lymphocyte Depletion Hodgkin Lymphoma, Adult Lymphocyte Predominant Hodgkin Lymphoma, Adult Mixed Cellularity Hodgkin Lymphoma, Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma, Adult Nodular Sclerosis Hodgkin Lymphoma

Studies at this site

• Genetic Mutational Analysis of Saliva or Buccal Mucosa Samples From Patients With Embryonal or Alveolar Rhabdomyosarcoma — Running, not enrolling
• Combination Chemotherapy, Autologous Stem Cell Transplant, and/or Radiation Therapy in Treating Young Patients With Extraocular Retinoblastoma — Completed
• Vorinostat, Temozolomide, or Bevacizumab in Combination With Radiation Therapy Followed by Bevacizumab and Temozolomide in Young Patients With Newly Diagnosed High-Grade Glioma — Completed
• Denosumab in Treating Patients With Recurrent or Refractory Osteosarcoma — Completed
• Cabozantinib S-Malate in Treating Younger Patients With Recurrent or Refractory Solid Tumors — Completed
• Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma — Completed
• Collecting and Storing Samples of Blood and Tumor Tissue From Patients With Osteosarcoma — Completed
• Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin Lymphoma — Completed
• Neoadjuvant Carboplatin and Vincristine and Standard Local Ophthalmic Therapy in Treating Patients With Intraocular Retinoblastoma — Completed
• Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas — Completed
• Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic Leukemia — Completed
• DNA Analysis of Tumor Tissue Samples From Young Patients With Acute Lymphoblastic Leukemia — Completed
• Music Therapy or Book Discussion in Improving Quality of Life in Young Patients Undergoing Stem Cell Transplant — Completed
• Study of Biomarkers in DNA Samples From Patients With Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia — Completed
• Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma — Completed
• DNA Biomarkers in Tissue Samples From Patients With Osteosarcoma — Completed
• Glembatumumab Vedotin in Treating Patients With Recurrent or Refractory Osteosarcoma — Completed
• Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia — Completed
• Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia — Completed
• Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia (Closed to Accrual 4-22-2011) — Completed
• Bortezomib, Ifosfamide, and Vinorelbine Tartrate in Treating Young Patients With Hodgkin's Lymphoma That is Recurrent or Did Not Respond to Previous Therapy — Completed
• Alisertib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia — Completed
• Collection of Bone Marrow From Donors Treated With or Without Filgrastim — Completed
• Collecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma — Completed
• DNA Analysis in Samples From Younger Patients With Germ Cell Tumors and Their Parents or Siblings — Completed
• Biomarker Study in Samples From Patients With Malignant Rhabdoid Tumor of the Kidney or Atypical Teratoid Rhabdoid Tumor — Withdrawn before enrolling
• Genetic Analysis Using Blood or Bone Marrow From Participants With Neuroblastoma or Noncancerous Conditions — Completed
• Studying Body Mass Index in Younger Patients Who Are Receiving Treatment for High-Risk Acute Lymphoblastic Leukemia — Withdrawn before enrolling
• Studying Biomarkers in Samples From Younger Patients With Kidney Cancer — Withdrawn before enrolling
• Sorafenib Tosylate in Treating Younger Patients With Relapsed or Refractory Rhabdomyosarcoma, Wilms Tumor, Liver Cancer, or Thyroid Cancer — Completed
• Carboplatin, Vincristine, and Temozolomide in Treating Children With Progressive and/or Symptomatic Low-Grade Glioma — Completed
• Ifosfamide, Carboplatin, Etoposide, and SGN-30 in Treating Young Patients With Recurrent Anaplastic Large Cell Lymphoma — Stopped early
• Motexafin Gadolinium and Radiation Therapy in Treating Young Patients With Pontine Glioma — Completed
• Trebananib in Treating Younger Patients With Relapsed or Refractory Solid Tumors, Including Central Nervous System Tumors — Completed
• Gene Analysis in Studying Susceptibility to Wilms Tumor — Completed
• Studying DNA in Blood and Bone Marrow Samples From Younger Patients With Acute Myeloid Leukemia — Completed
• Biomarkers in Patients With Advanced Rhabdomyosarcoma — Completed
• Study of Specimens From Young Patients With Neuroblastoma — Completed
• Sunitinib Malate in Treating Younger Patients With Recurrent, Refractory, or Progressive Malignant Glioma or Ependymoma — Completed
• Vincristine Sulfate, Topotecan Hydrochloride, and Cyclophosphamide With or Without Bevacizumab in Treating Young Patients With Refractory or First Recurrent Extracranial Ewing Sarcoma — Completed
• Vorinostat With or Without Isotretinoin in Treating Young Patients With Recurrent or Refractory Solid Tumors, Lymphoma, or Leukemia — Completed